Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Ramakrishnan Geethakumari, P."'
Autor:
Santiago Mercadal, Kwang Woo Ahn, Mariam Allbee-Johnson, Siddhartha Ganguly, Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana Malone, Hemant Murthy, Attaphol Pawarode, Alejandro R. Sica, Melhem Solh, Celalettin Ustun, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Externí odkaz:
https://doaj.org/article/0f51ee9132d14a23b24194148fb6258b
Autor:
Narendranath Epperla, Rina Li Welkie, Pallawi Torka, Geoffrey Shouse, Reem Karmali, Lauren Shea, Andrea Anampa-Guzmán, Timothy S. Oh, Heather Reaves, Montreh Tavakkoli, Kathryn Lindsey, Irl Brian Greenwell, Emily Hansinger, Colin Thomas, Sayan Mullick Chowdhury, Kaitlin Annunzio, Beth Christian, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Alex F. Herrera, Natalie S. Grover, Adam J. Olszewski
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-6 (2023)
Abstract Progression of disease within 24 months (POD24) from diagnosis in marginal zone lymphoma (MZL) was shown to portend poor outcomes in prior studies. However, many patients with MZL do not require immediate therapy, and the time from diagnosis
Externí odkaz:
https://doaj.org/article/4835afa60d3d4971aa7119bfb3356cb7
Autor:
Aditi Mulgaonkar, Durga Udayakumar, Yaxing Yang, Shelby Harris, Orhan K. Öz, Praveen Ramakrishnan Geethakumari, Xiankai Sun
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Chimeric antigen receptor (CAR) T-cell therapies have evolved as breakthrough treatment options for the management of hematological malignancies and are also being developed as therapeutics for solid tumors. However, despite the impressive patient re
Externí odkaz:
https://doaj.org/article/f1f1996dcbf2454e873de44322b482f4
Autor:
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Ibrutinib is effective in the treatment of relapsed/refractory (R/R) marginal zone lymphoma (MZL) with an overall response rate (ORR) of 48%. However, factors associated with response (or lack thereof) to ibrutinib in R/R MZL in clinical pra
Externí odkaz:
https://doaj.org/article/742e9377f2884da1b8eeb0b6ff560e57
Autor:
Kandice A. Kapinos, Ellen Hu, Jigar Trivedi, Praveen Ramakrishnan Geethakumari, Ankit Kansagra
Publikováno v:
Cancer Control, Vol 30 (2023)
Objectives Among advanced multiple myeloma (MM) patients, B-cell maturation antigen (BCMA) specific targets like Belantamab Mafodotin (belamaf) and CAR T-cell therapies have been shown to improve clinical outcomes, but at significant costs. To compar
Externí odkaz:
https://doaj.org/article/aa3cd8886ab7425889047fd32c8b3cf8
Autor:
Elizabeth McGehee, Hetalkumari Patel, Caroline Pearson, Keri Clements, Jesse Manuel Jaso, Weina Chen, Alexandra Callan, Neil Desai, Praveen Ramakrishnan Geethakumari
Publikováno v:
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)
Abstract Background Extranodal natural killer/T-cell lymphoma is a rare, aggressive non-Hodgkin lymphoma that is treated upfront mostly with L-asparaginase containing regimens. Relapsed extranodal natural killer/T-cell lymphoma is associated with a p
Externí odkaz:
https://doaj.org/article/65497ad02c8a4cbf9f91cd0d6b4f973f
Autor:
P. Strati, M. Coleman, D. Stevens, S. Ma, C. Patti, M. Levy, I. S. Lossos, P. Ramakrishnan Geethakumari, S. Lam, R. Calvo, K. Higgins, L. Budde
Publikováno v:
HemaSphere, Vol 6, Pp 1019-1020 (2022)
Externí odkaz:
https://doaj.org/article/290c538427004c2bb70ea9fc74afd57f
Autor:
Mohsin Soleja, Jesse Manuel Jaso, Weina Chen, Jack Raisanen, Christian A. Wysocki, Yu‐Min Shen, Bruce Mickey, Kiran A. Kumar, Praveen Ramakrishnan Geethakumari
Publikováno v:
Clinical Case Reports, Vol 9, Iss 9, Pp n/a-n/a (2021)
Abstract Isolated central nervous system lymphomatoid granulomatosis (CNS‐LYG) can mimic aggressive glioblastomas. We describe a complex presentation of CNS‐LYG coexisting with immune thrombocytopenia successfully managed with rituximab and ultra
Externí odkaz:
https://doaj.org/article/1673a2faf2d849e6976966fea289a728
Autor:
Lenin Mahimainathan, Madhusudhanan Narasimhan, Rolando Corchado, Hetalkumari Patel, Ankit Kansagra, Sridevi Devaraj, Praveen Ramakrishnan Geethakumari, Alagarraju Muthukumar
Publikováno v:
Diagnostics, Vol 10, Iss 12, p 992 (2020)
Background: Patients with hematological malignancies (HM), including multiple myeloma (MM), frequently suffer from immune deficiency-associated infectious complications because of both the disease and the treatment. Alarming results from China and th
Externí odkaz:
https://doaj.org/article/2e5691ee8f4643a4b45371d41bc1289a
Autor:
Annunzio, Kaitlin, Grover, Natalie S., Welkie, Rina Li, Torka, Pallawi, Watkins, Marcus P., Anampa-Guzmán, Andrea, Tavakkoli, Montreh, Oh, Timothy S., Reves, Heather, Jones, Daniel, Hanel, Walter, Christian, Beth, Ramakrishnan Geethakumari, Praveen, Karmali, Reem, Barta, Stefan K., Bartlett, Nancy L., Olszewski, Adam J., Epperla, Narendranath
Publikováno v:
Blood Advances; November 2023, Vol. 7 Issue: 22 p6839-6843, 5p